Safilens has obtained U.S. patent approval for its Safe Gel contact lens technology and is awaiting the go-ahead of the U.S. Food & Drug Administration to market it through Two Tower Frames, the company's distributor for North and Central America.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.